Skip to content

H04 — TCM evidence qualification as a gout-exploit discovery method

Evidence status: Stub. This is a hypothesis about research method performance, not an efficacy claim for any material or formula.

Provisional claim

A workflow that combines multilingual traditional-name discovery with primary-evidence records preserving material identity, target-effect polarity, assay context, exposure, and function will produce at least one non-obvious, falsifiable gout-exploit hypothesis that would be missed by either:

  • database-only compound aggregation; or
  • formula-level efficacy summaries without component and target attribution.

The output must be more than a larger catalog. A useful success is a grounded connection with a discriminating experiment and a clear decision boundary.

What counts as a success

At least one bounded case must meet all of these conditions:

  1. the source material and primary record are verified;
  2. the gout weakness and effect polarity are explicit;
  3. the novel connection is not presented as established fact;
  4. the cheapest experiment could advance, redirect, or kill the connection;
  5. the result changes a research decision: which evidence to collect, which assay to run, or which combination to test.

A compound recommendation, human dose, formula priority, or production chassis is not required and cannot be inferred from method success.

Load-bearing assumptions

  1. Traditional names, formula names, species names, and traditional pathology terms retrieve relevant evidence that mechanism-only searches miss.
  2. Primary records contain enough material and assay detail to prevent compound, extract, and formula evidence from being merged.
  3. Preserving effect polarity and endpoint type prevents an off-target or expression signal from being counted as a favorable functional mechanism.
  4. Local-delivery hypotheses remain testable when free exposure and mechanism-matched function are measured rather than inferred from poor absorption.
  5. Formula decomposition can distinguish a real interaction from redundant ingredients or modern retrospective storytelling.

Killshot menu

  • No added insight: a bounded sample produces no new testable connection or decision beyond what the source papers already state.
  • Material irreproducibility: the relevant extract or formula cannot be compositionally standardized enough to reproduce the claimed signal.
  • Mechanism collapse: direct function, exposure, or attribution tests fail for the proposed target under the relevant tissue and substrate conditions.
  • Formula interaction failure: a standardized full formula does not outperform components and declared combinations under the prespecified additivity model.
  • Search-frame failure: traditional-name and original-language queries add no relevant primary evidence beyond mechanism-only searches in a preregistered comparison.

Failure narrows the method or the tested lead. It does not imply that TCM-derived materials as a class are active or inactive.

Current test path

  • COMP-013 is invalidated and cannot test H04.
  • COMP-049 is the pre-run mixed-source evidence-qualification replacement. It tests record fidelity, simultaneous gap detection, and experiment routing—not whether H04 is true.
  • The formula Research Conjecture supplies one candidate connection for a later factorial experiment.

Status

Stub. No H04 killshot has been executed. Survival count remains 0.